Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 471,430 | 534,862 | 472,787 | 516,150 | 411,155 |
| Marketable Securities | 139,144 | 138,901 | 165,833 | 188,164 | 211,443 |
| Receivables | 89,935 | 101,563 | 103,921 | 98,562 | 117,240 |
| Inventories | 14,237 | 13,872 | 20,070 | 23,761 | 28,291 |
| Income taxes - deferred | N/A | N/A | 87,367 | 80,858 | 86,937 |
| TOTAL | $737,941 | $821,229 | $895,529 | $942,018 | $892,158 |
| Non-Current Assets | |||||
| PPE Net | 410,063 | 403,091 | 386,448 | 358,368 | 330,249 |
| Investments And Advances | 266,904 | 321,015 | 373,498 | 330,298 | 318,448 |
| Intangibles | 532,525 | 435,215 | 430,180 | 419,238 | 424,011 |
| Other Non-Current Assets | 166,171 | 152,743 | 65,980 | 64,682 | 57,553 |
| TOTAL | $1,375,663 | $1,312,064 | $1,256,106 | $1,172,586 | $1,130,261 |
| Total Assets | $2,113,604 | $2,133,293 | $2,151,635 | $2,114,604 | $2,022,419 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,207 | 20,710 | 27,566 | 14,130 | 9,973 |
| Accrued Expenses | 159,635 | 169,307 | 163,776 | 189,507 | 159,360 |
| TOTAL | $196,535 | $209,681 | $209,358 | $221,152 | $192,323 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 21,992 | 18,910 | 18,016 | 16,371 | 21,236 |
| Other Non-Current Liabilities | 70,964 | 76,662 | 72,283 | 64,157 | 55,213 |
| TOTAL | $104,887 | $107,605 | $102,294 | $94,393 | $78,996 |
| Total Liabilities | $301,422 | $317,286 | $311,652 | $315,545 | $271,319 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 100,796 | 100,851 | 102,672 | 102,716 | 102,593 |
| Common Shares | 101 | 102 | 104 | 103 | 103 |
| Retained earnings | 1,816,318 | 1,800,857 | 1,764,578 | 1,739,346 | 1,691,614 |
| Other shareholders' equity | -4,237 | -2,523 | 9,715 | 8,948 | 13,904 |
| TOTAL | $1,812,182 | $1,816,007 | $1,839,983 | $1,799,059 | $1,751,100 |
| Total Liabilities And Equity | $2,113,604 | $2,133,293 | $2,151,635 | $2,114,604 | $2,022,419 |